RESULTS	Fatal and non-fatal stroke ( 89 atorvastatin vs 121 placebo , 0.73 [ 0.56-0 .96 ] , p = 0.024 ) , total cardiovascular events ( 389 vs 486 , 0.79 [ 0.69-0 .90 ] , p = 0.0005 ) , and total coronary events ( 178 vs 247 , 0.71 [ 0.59-0 .86 ] , p = 0.0005 ) were also significantly lowered .\